(R)-MG132 is a potent, reversible, and cell-permeable proteasome inhibitor. After treatment for one hour at 100 nM, it inhibits 50% and 31% of proteasome activity in lysates of J558L multiple myeloma cells and EMT6 breast cancer cells, respectively.
CAT# | R1874 |
CAS | 1211877-36-9 |
Chemical Name | benzyl N-[(2S)-4-methyl-1-[[(2R)-4-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate |
M.F/Formula | C26H41N3O5 |
M.W/Mr. | 475.6 |
Sequence | One Letter Code: Cbz-LLL Three Letter Code: Cbz-Leu-D-Leu-Leu-al |
Purity | ≥97% by HPLC |
Activity | Potent 20S proteasome inhibitor (IC50 = 0.22 nM). Exhibits cytostatic and cytotoxic effects in tumor cells in vitro. |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Secretin is a 27 amino acid polypeptide that is released during acidification in the duodenal cavity and stim ...
Factors of natural aging Natural aging of the skin results in decreased production and increased degradation of extracellula ...
KAI-1455, a ε-protein kinase C activator in Phase I testing for the treatment of ischemia-induced reperfusion i ...
Purotoxin 1, a component from the venom of Geolycosa spiders, exerts selective inhibitory action on P2X3 recep ...
Development of Trofinetide Trofinetide was found in 2002 by Brimble's team at the University of Auckland i ...